2015
Screening for Critical Congenital Heart Disease in Newborns
Bruno CJ, Havranek T. Screening for Critical Congenital Heart Disease in Newborns. Advances In Pediatrics 2015, 62: 211-226. PMID: 26205115, DOI: 10.1016/j.yapd.2015.04.002.Peer-Reviewed Original ResearchConceptsCongenital heart diseasePulse oximetryHeart diseaseCritical congenital heart diseaseNewborn screening toolPrompt patient evaluationHours of lifeNewborn pulse oximetryForm of surgeryPositive screening resultsAsymptomatic patientsCardiac catheterizationCardiovascular collapseClinical presentationPatient evaluationCritical neonatesNeonatesCCHDTimely interventionPatientsScreening toolOximetryScreening resultsStandardized mannerOutcomes
2013
Parotid gland lymphoma: Prognostic analysis of 2140 patients
Feinstein AJ, Ciarleglio MM, Cong X, Otremba MD, Judson BL. Parotid gland lymphoma: Prognostic analysis of 2140 patients. The Laryngoscope 2013, 123: 1199-1203. PMID: 23576299, DOI: 10.1002/lary.23901.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge DistributionAgedAged, 80 and overChildChild, PreschoolDisease-Free SurvivalFemaleHumansIncidenceInfantInfant, NewbornKaplan-Meier EstimateLymphomaMaleMiddle AgedParotid NeoplasmsPrognosisProportional Hazards ModelsRetrospective StudiesSEER ProgramSex DistributionSurvival RateUnited StatesYoung AdultConceptsParotid gland lymphomaFacial nerve sacrificeB-cell lymphomaNerve sacrificeHodgkin's lymphomaMarginal zone B-cell lymphomaEnd Results Program databaseKaplan-Meier survival curvesCox proportional hazards modelNon-Hodgkin lymphoma subtypesLarge B-cell lymphomaUS population-based dataRetrospective cohort studyRole of chemotherapyLog-rank testPopulation-based dataForm of surgeryProportional hazards modelCohort studyPatient agePathologic featuresPrognostic importanceMale genderProgram databaseLymphoma subtypes
2009
Chapter 98 The Use of 131Iodine in the Treatment of Graves’ Disease in Children
Rivkees S, Dinauer C. Chapter 98 The Use of 131Iodine in the Treatment of Graves’ Disease in Children. 2009, 942-955. DOI: 10.1016/b978-0-12-374135-6.00098-4.ChaptersGraves' diseaseRadioactive iodineThyroid cancerSide effectsLong-term adverse side effectsLong-term remission ratesRecurrent laryngeal nerve paresisPreferred definitive treatmentTreatment of GravesAcute side effectsBone marrow suppressionLaryngeal nerve paresisLong-term complicationsSerious adverse reactionsCurrent treatment optionsHigh cure ratesLarge thyroid glandForm of surgeryAdverse side effectsGenetic damageAntithyroid medicationDefinitive therapyNerve paresisPermanent hypoparathyroidismRemission rate
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply